// App-Quantinova.ai

BSH2020‐OR‐038 : Analysis of second line treatments for children with persistent or chronic primary immune thrombocytopenia (ITP) in the UK

Researchers

Presenter

  • B. Chaudhury

Principal Investigators

  • N. Seymour

  • J. Grainger

Medical Centers

  • Manchester Medical School, University of Manchester

  • Department of Paediatric Oncology and Haematology, Manchester University Hospitals NHS foundation Trust

  • Department of Paediatric Endocrinology, Royal Manchester Childrens Hospital, Manchester, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved